A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters.

Trial Profile

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2014

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Acronyms TROPICS-1
  • Sponsors Genentech
  • Most Recent Events

    • 22 Dec 2009 New trial record
    • 07 Dec 2009 Primary endpoint 'Catheter clearance rate' has been met.
    • 05 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH-2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top